Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease in the New England Journal of Medicine
TOKYO, Nov 30, 2022 – (J […]
New Horizon Health Announced 2022 Interim Report: Revenue Up 414% YoY, Gross Margin Climbs to 82%
HANGZHOU, Aug 19, 2022 – […]
Investigational Alzheimer’s Disease Therapy Lecanemab Granted FDA Fast Track Designation
TOKYO, Dec 24, 2021 – (J […]
Giant panda cub turns 100 days old, expected to join public exhibit early next year
SINGAPORE – The Republic […]
Topelia Australia launches US$25M Series A call for COVID-19 ATT Ziverdox
SYDNEY, Oct 14, 2021 – ( […]
US stocks end mostly higher, shrugging off early weakness
NEW YORK (AFP) – Wall St […]
Japan factory activity expands at fastest pace since early 2018
TOKYO (REUTERS) – Japan& […]
Me & My Money: Hatch early saving plan and bank on professionals to grow nest egg
SINGAPORE – Getting your […]
Pound drops after leaders dinner fails to break Brexit impasse
SINGAPORE (BLOOMBERG) – […]
Despite early doubts, former nurse finds success working in pre-school
SINGAPORE – The sight an […]